CLINICAL_TRIALS
trial_result
· 2014-11-24
Clinical Trial Update: Wellbutrin XL for Dysthymic Disorder [Phase 4]
Summary
Phase 4 trial of Wellbutrin XL for dysthymic disorder completed; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: St. Luke's-Roosevelt Hospital Center | Conditions: Dysthymic Disorder | Phase 4 | Status: COMPLETED | Results posted: 2014-11-24